Stocks
Adaptive Biotechnologies (ADPT) Net margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -134.3% | -108.0% | -132.3% | -89.1% | -21.5% | -16.8% | ||
| Changes by years, y/y, % | +14pp | +26pp | -24pp | +43pp | +68pp | -32.1% | |||
Adaptive Biotechnologies. Net margin, %
Adaptive Biotechnologies. Net margin, changes, pp
Adaptive Biotechnologies (ADPT) Net margin US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| Net margin, % | ? | 10.2% | -18.9% | -28.3% | -64.6% | -55.6% | -16.8% | |
| Changes by years, y/y, % | +79pp | +52pp | +29pp | -21pp | -12pp | |||
| Changes by quarters, q/q, % | +54pp | -29pp | -9pp | -36pp | +9pp | |||
